While all eyes on fixated on global stock markets as the measure of “prosperity” and “growth” (or is it hubris?), the larger force at work beneath the dovish cooing of central bankers is foreign exchange: the relative value of nations’ currencies, which are influenced (like everything else) by supply and demand, which is in turn influenced…
USDJPY: The pair extended its weakness on Monday leaving lower towards its key support located at the 111.66 level. On the downside, support comes in at the 111.00 level where a break if seen will aim at the 110.50 level. A cut through here will turn focus to the 110.00 level and possibly lower towards…
The session on Tuesday features of the ISM Non-manufacturing PMI numbers coming out of America, and the Australian central bank releasing its monetary policy statement an interest-rate decision. With this being said, it is not likely to be a major shift in momentum as far as the markets are concerned during the day, but those…
Shares of Groupon (GRPN) rallied in morning trading after the company announced a $250M investment from Atairos, the company founded by former Comcast (CMCSA, CMCSK) vice chairman and chief financial officer Michael Angelakis. As a result of the investment, Groupon said that Comcast will work with it to identify and implement possible partnership opportunities and…
Shares of Groupon (GRPN) rallied in morning trading after the company announced a $250M investment from Atairos, the company founded by former Comcast (CMCSA, CMCSK) vice chairman and chief financial officer Michael Angelakis. As a result of the investment, Groupon said that Comcast will work with it to identify and implement possible partnership opportunities and…
Healthcare Sector Leads the Market Lagging healthcare and biotech stocks found buyers today. The healthcare SPDR ETF (XLV) was up 1.05% to $69.38 as investors were probably seeking dividends and safety with fears about pricing tempered. The XLV is still down 3.68% YTD. Biotechs came out of the box strong but sold off as the…
Albert discusses his recent interview with James Rickards and takes apart an Financial Times article critical of gold investors. Video Length: 00:18:25
Back in November and December of 2014, we released a 7 part series highlighting the weight of evidence piling up against U.S. stocks. In summary, our research showed a market top was upon us. If you weren’t with us back then, you can catch up and dig into our methods using the links below. This…
American voters are expressing a lack of confidence in free trade and question whether the purpose of a corporation is to maximize shareholder wealth. These two ideas have guided U.S. economic policies for decades. Why are they tarnished in the minds of voters across the political spectrum? Three developments help explain this question: the end…
The 2016 Q1 earnings season takes center stage with Alcoa’s (AA – Analyst Report) release after the close on Monday. Alcoa isn’t the overall first to report Q1 results, though it is the first S&P 500 member with a fiscal March quarter to come out with results. Companies with fiscal quarters ending in February have…
